Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06448234
Status:
COMPLETED
Last Update Posted:
2024-06-11
First Post:
2024-06-03
Brief Title:
Evaluating the Efficacy of AI-Guided GenAIS TM vs Standard Physician-Guided Dietary Supplement Prescriptions for Lowering LDL Cholesterol in Hypercholesterolemic Patients
Sponsor:
SLAB SOLOWAYS
Organization:
SLAB SOLOWAYS
Study Overview
Official Title:
Evaluating the Efficacy of AI-Guided vs Standard Physician-Guided Dietary Supplement Prescriptions for Lowering LDL Cholesterol in Hypercholesterolemic Patients A Randomized Controlled Pilot Trial
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The trial compared AI-guided and standard physician-guided dietary supplement DS prescriptions for lowering LDL cholesterol LDL-C in hypercholesterolemic patients The AI system used genetic metabolic and clinical data to personalize DS regimens hypothesizing superior efficacy over traditional methods This 3-month randomized controlled trial involved adults aged 40-75 with specific LDL-C levels excluding those with significant health risks Participants were divided into a control group with physician-guided DS and an AI-guided group The AI system from Triangel Scientific provided dynamic personalized recommendations Baseline and follow-up measurements included lipid profiles and adherence assessments The AI-guided group showed significantly greater LDL-C reduction and improvement in other lipid markers The study concluded that AI-guided DS prescriptions are more effective suggesting a promising future for AI in personalized cholesterol management
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None